Each month we provide an overview of University of Missouri authored articles in medicine and related fields as well as a featured article from a School of Medicine author with the highest journal impact factor.
“Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial” was co-authored by Dr. Daniel Hoernschemeyer of the Department of Orthopaedic Surgery. The article was published in The Lancet (impact factor of 60.392 in 2019).
See the list of publications in medicine and related fields we retrieved for this month: https://library.muhealth.org/code/facultypubmonthly/faculty_publications.php?Month=September&Year=2020
*This list is not intended to be comprehensive.
Did we miss something? Email email@example.com and we will add your publication to the list.